Effect of the antiglucocorticoid RU-486 on glomerular hemodynamics in remnant nephrons

Area of Science:

• Nephrology
• Endocrinology
• Pharmacology

Background:

• Endogenous glucocorticoids (GCs) are implicated in remnant nephron adaptation and renal disease progression.
• Understanding GC's role is crucial for managing chronic renal failure (CRF).

Purpose of the Study:

• To investigate the effect of GC blockade using RU-486 on CRF progression in a rat model.
• To determine GC's involvement in adaptive hyperfiltration, proteinuria, and glomerulosclerosis.

Main Methods:

• Chronic renal failure (CRF) induced by 5/6 nephrectomy in Munich-Wistar rats.
• GC blockade administered via RU-486 (20 mg/kg).
• Evaluated global renal function, glomerular hemodynamics, proteinuria, and renal histopathology after 60 days.

Main Results:

• RU-486 did not alter total renal function, arterial pressure, proteinuria, or sclerosis index.
• Significant reduction in single-nephron glomerular filtration rate (GFR) observed in superficial nephrons (20% in controls, 57% in CRF).
• Reductions in single-nephron GFR were attributed to decreased glomerular plasma flow rate (QA) and ultrafiltration coefficient (Kf).

Conclusions:

• Glucocorticoids play a role in the adaptive hyperfiltration compensating for reduced nephron mass.
• GC blockade did not prevent or worsen proteinuria or glomerulosclerosis in this experimental model.
• GC's primary role appears to be in the compensatory hyperfiltration mechanism, not disease pathogenesis.